Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
The global Vitamin K2 market is projected to grow from USD 179.0 million in 2026 to USD 339.9 million by 2031, registering a 13.7% CAGR. Growth is driven by rising demand for bone and cardiovascular health supplements, preventive healthcare, functional nutrition, and clean-label ingredients. MK-7 is expected to dominate due to its high bioavailability, while pharmaceuticals offer significant growth potential. Asia Pacific will be the fastest-growing region, supported by aging populations and e-c
Balchem has delivered a 35.5% return over the past 3 years, which naturally prompts the question of whether the current share price is well supported by the cash the business can generate. With the stock recently closing at US$167.84, the gap between the recent share-price path and the underlying cash flows is what matters most for investors now. The 35.5% return over 3 years highlights the importance of assessing whether Balchem's current market value aligns with the cash it is expected to...
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
MONTVALE, N.J., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the 9th Annual Wells Fargo Consumer Conference on September 23, 2026. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer and Allison Baurichter, Senior Director Investor Relations will participate in the conference. About Balchem Corpor
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.